BMJ Open Respiratory Research

Papers
(The H4-Index of BMJ Open Respiratory Research is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Protection conferred by SARS-CoV-2 infection across a spectrum of reinfection symptoms and severities80
Extracorporeal CO2 removal in acute exacerbation of COPD unresponsive to non-invasive ventilation77
Bagasse dust exposure and chronic respiratory symptoms among workers in the Metehara and Wonji sugar factories in Ethiopia: a longitudinal study design73
Effect of a home-based inspiratory muscle training programme on functional capacity in postdischarged patients with long COVID: the InsCOVID trial70
Comparing the impact of targeting limited driving pressure to low tidal volume ventilation on mortality in mechanically ventilated adults with COVID-19 ARDS: an exploratory target trial emulation68
Genomic testing for children with interstitial and diffuse lung disease (chILD): parent satisfaction, understanding and health-related quality of life59
Chronic obstructive pulmonary disease is a risk factor for non-tuberculous mycobacterial pulmonary disease: a population-based matched cohort study48
Differences in risk indicators associated with electronic cigarette use and tobacco smoking among adolescents and young people in Nigeria44
Differences in uni-dimensional breathlessness measures and thresholds for clinical response in a randomised controlled trial in people with chronic breathlessness: an exploratory study44
Malignant pleural mesothelioma patients’ experience by gender: findings from a cross-sectional UK-national questionnaire39
Comparison of the efficacy of novel two covering methods for spontaneous pneumothorax: a multi-institutional study35
Methamphetamine-associated pulmonary arterial hypertension: data from the national biological sample and data repository for pulmonary arterial hypertension (PAH Biobank)35
Association between birth weight and chronic obstructive pulmonary disease in the UK Biobank: a prospective cohort study34
Evaluation of the Norwegian version of the Dyspnoea-12 questionnaire in patients with COPD33
Contribution of collagen XIII to lung function and development of pulmonary fibrosis32
Lung Health Check pilot: Ireland’s flagship lung cancer screening trial30
Impact of early caffeine administration on respiratory outcomes in very preterm infants initially receiving invasive mechanical ventilation27
IPDMA – RADICAL – NSCLC: individual participant data meta-analysis and systematic review of radical local therapy for oligometastatic NSCLC27
Serum KL-6 levels predict clinical outcomes and are associated with MUC1 polymorphism in Japanese patients with COVID-1927
Characterisation of patients with chronic obstructive pulmonary disease initiating single-device inhaled corticosteroids/long-acting β2-agonist dual therapy in a primary care setting in Eng26
Association of high-sensitivity CRP and FEV1%pred: a study on non-pulmonary disease in a population in Beijing, China24
Temperature synchronisation of circadian rhythms in primary human airway epithelial cells from children24
What if… your research is suddenly affiliated with a tobacco manufacturing company?22
Antibody responses and risk factors associated with impaired immunological outcomes following two doses of BNT162b2 COVID-19 vaccination in patients with chronic pulmonary diseases22
Therapeutic effects of fatty acid binding protein 1 in mice with pulmonary fibrosis by regulating alveolar epithelial regeneration22
0.091095924377441